Félix d'Herelle

Félix d’Hérelle developed as a largely self-directed microbiologist whose career crossed several countries and institutions. Born in Montreal in 1873, he spent formative years in Europe and later worked in Guatemala, Mexico, and Canada before joining the Institut Pasteur in Paris.¹ He had no conventional university career in microbiology, and his practical experience with fermentation, infectious disease, and field investigations shaped his experimental style.

His early work included studies of microbial processes and diseases affecting humans, animals, and agricultural production. During an outbreak of severe dysentery among French troops in 1917, he examined cultures of the dysentery bacterium Shigella. The episode redirected his career toward an invisible antibacterial agent that could pass through filters and multiply only in the presence of susceptible bacteria.²

D’Hérelle’s central contribution was the recognition that clear areas in bacterial cultures represented replication of a virus that attacks bacteria. He called the agent a bacteriophage, from Greek roots meaning “bacteria eater,” and reported the finding to the French Academy of Sciences in 1917.¹ Earlier investigators, including Frederick Twort, had observed related bacterial-dissolving phenomena, but d’Hérelle developed a systematic interpretation and experimental program around them.

His method involved filtering material from dysentery patients, mixing the filtrate with bacterial cultures, and observing sharply defined plaques where bacteria had been destroyed. Repeated transfer of material from plaques suggested multiplication rather than a merely chemical antibacterial effect. This plaque assay became a foundational technique in phage biology and later helped researchers measure viral particles and study mutation, host range, and bacterial resistance.³

D’Hérelle treated bacteriophages as possible medicines and helped make phage therapy an international medical experiment. He tested preparations against dysentery and other bacterial infections, and commercial or institutional phage products appeared in several countries during the 1920s and 1930s, before antibiotics became dominant.³ His approach included oral administration and local treatment, although the quality, purity, dosing, and diagnostic matching of early preparations varied considerably.

In 1923 he went to Tbilisi, then in the Georgian Soviet Republic, where he collaborated with Georgian physician George Eliava. Their work contributed to the development of the Eliava Institute, which remains associated with therapeutic phage research.⁴ D’Hérelle also held positions in North America and Europe and trained or influenced investigators who carried phage research into bacterial genetics, ecology, and experimental medicine. Western interest declined after penicillin and other antibiotics proved easier to standardize, while phage therapy continued in parts of Eastern Europe.

D’Hérelle’s importance extends beyond the discovery story because his ideas anticipated several later fields. He proposed that phages might regulate bacterial populations in nature and the human body, an intuition related to modern work on the microbiome, microbial ecology, and phage–host coevolution.⁵ He also viewed bacterial viruses as experimentally tractable entities, helping create a research culture that eventually connected phage biology with molecular genetics.

His legacy is not identical to proof that every historical treatment worked: many early clinical reports lacked controls and used poorly characterized preparations. Contemporary phage therapy therefore emphasizes genome sequencing, removal of undesirable genes, manufacturing quality, susceptibility testing, and carefully designed clinical trials.⁵ The renewed interest reflects antibiotic resistance, but modern practice retains d’Hérelle’s basic insight while applying standards that were unavailable in his lifetime.

Bacteriophage

A virus that infects bacteria and, in many cases, destroys the host cell during replication.

Plaque

A visible cleared zone in a lawn of bacteria produced by infection and lysis by phages.

Phage therapy

The treatment of bacterial infection with selected bacteriophages.

Shigella

A genus of bacteria that includes causes of bacillary dysentery and was central to d’Hérelle’s early phage investigations.